0001238403-21-000002.txt : 20210528 0001238403-21-000002.hdr.sgml : 20210528 20210528184814 ACCESSION NUMBER: 0001238403-21-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210527 FILED AS OF DATE: 20210528 DATE AS OF CHANGE: 20210528 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SPIEGELMAN DANIEL K CENTRAL INDEX KEY: 0001238403 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26642 FILM NUMBER: 21982240 MAIL ADDRESS: STREET 1: MYRIAD GENETICS STREET 2: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84003 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYRIAD GENETICS INC CENTRAL INDEX KEY: 0000899923 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 870494517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 BUSINESS PHONE: 801-584-3600 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-05-27 0 0000899923 MYRIAD GENETICS INC MYGN 0001238403 SPIEGELMAN DANIEL K 320 WAKARA WAY SALT LAKE CITY UT 84108 1 0 0 0 Common Stock 2021-05-27 4 D 0 15889 0.0 D 20562 D On May 27, 2021, the Company rescinded Mr. Spiegelman's grant of 15,889 restricted stock units granted on December 4, 2020 and reported on the Form 4 filed with the Securities and Exchange Commission on December 7, 2020. By: Nathan A. Smith For: Daniel K. Spiegelman 2021-05-28